Craig Tendler, M.D. is Vice President and Global Head of Clinical Development, Diagnostics, and Medical Affairs for the Oncology Therapeutic Area at Janssen Research & Development, one of the Janssen Pharmaceutical Companies of Johnson & Johnson. In this position, he [...]
Tara Frenkl, MD, MPH is the Head of Oncology Development at Bayer’s Oncology Strategic Business Unit. Prior to joining Bayer, she held the role of Senior Vice President, Head of Medicine Development Leaders in Oncology at GlaxoSmithKline, with strategic impact [...]
Jean-Charles Soria is Amgen’s Senior Vice President of Oncology within Global Development. Soria joined Amgen from Institut Gustave Roussy, where he was appointed director general by France’s Minister of Health and Solidarity. Soria is a medical oncologist and professor of [...]
Dr. Eliav Barr became head of Global Clinical Development (GCD) and Chief Medical Officer, Merck Research Laboratories (MRL), in April 2022. Previously he was Senior Vice President, Global Clinical Development and he has held positions of increasing responsibility including leadership [...]
Dr. Peter Sandor has 25 years of biopharmaceutical leadership experience and currently serves as the senior vice president, Primary Focus Lead, Primary Focus Immuno-oncology at Astellas.In his role, Dr. Sandor has responsibility for leading the strategic direction of Astellas’ early [...]
Stu Bailey is senior vice president, head of clinical measurement sciences at EMD Serono, Inc.. He previously served as vice president, head of analytics and data sciences at Biogen and global head of early development biostatistics at Novartis Institutes for [...]
Emily Morris-McCarthy is the general manager, head U.S. oncology for Sanofi. She previously served as franchise head for alliance/immuno-oncology and senior director of marketing for U.S. immuno-oncology marketing at Sanofi. Before coming to Sanofi, she was senior director of U.S. [...]
Brian Alexander, MD, was named Chief Executive Officer of Foundation Medicine in March 2021. He previously served as the company’s Chief Medical Officer, and practiced radiation oncology specializing in neuro-oncology at Dana-Farber Brigham Cancer Center. He is also a Senior [...]
William C. Weldon is Chairman of the Board of Johnson & Johnson. He assumed his current responsibilities in April, 2002. Previously Bill served as Worldwide Chairman, Pharmaceuticals Group, and a Vice Chairman of the Board of Directors. He was elected [...]
Dr. Martin J. Murphy in 1999 accepted the challenge from President George H. W. Bush to help create and lead what would become the CEO Roundtable on Cancer as its Founding Chief Executive Officer, a role he which he served [...]
Robert A. Bradway is Amgen’s chairman and chief executive officer. Bradway became chairman in January 2013 and chief executive officer in May 2012. Bradway served as the company’s president and chief operating officer from May 2010 to May 2012, and [...]
Robert “Bob” Ingram (1942-2023) was General Partner at Hatteras Venture Partners, a venture capital firm that invests in early stage life science companies. Prior to joining Hatteras, Mr. Ingram was Chief Executive Officer and Chairman of Glaxo/Wellcome. Mr. Ingram co-led [...]
Scott White is Company Group Chairman, North America, at the Janssen Pharmaceutical Companies of Johnson & Johnson. A member of the Pharmaceuticals Group Operating Committee, he is responsible for leading Janssen’s efforts to transform the health of people in the [...]
Peter WT Pisters, M.D., took the helm as president of The University of Texas MD Anderson Cancer Center in 2017, and forged a new path forward to end cancer by transforming the culture of the nation’s top-ranked cancer center. With a [...]
Dr. Sharpless led the National Cancer Institute (NCI) from 2017 to 2022. He was appointed acting commissioner of the U.S. Food and Drug Administration (FDA) in 2019 and served for seven months before returning to his position at the NCI. [...]
Since 2009, Major General Granger has been the President and CEO of THE 5Ps, LLC, a health care, education, and leadership consulting organization in Colorado. Prior to his retirement from the US Army in 2009, Dr. Granger served as the Deputy Director and [...]
John co-founded Hatteras in 2000 after a successful career as a technology entrepreneur. After a decade in politics and public policy, he was founder and CEO of E-Comm, Inc., a software development and services firm specializing in remote and mobile [...]
As the CEO of SAS, the world’s leading business analytics software vendor, Jim Goodnight has led the company since its inception in 1976, overseeing an unbroken chain of revenue growth and profitability unprecedented in the industry. He is recognized globally [...]